Marta Coscia

21PUBLICATIONS
117CO-AUTHORS
Other biological sciences not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Apr 02, 2026
No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12.

Luca Laurenti, Feliciana Guglielmi, Antonio Mosca

|Jan 07, 2026
Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort.

Enrica Antonia Martino, Annalisa Pitino, Ernesto Vigna

|Nov 10, 2025
Clinical Presentation, Treatment, and Outcomes of 28 Patients With Castleman Disease: A Retrospective Analysis of an Italian Cohort.

Caterina Cristinelli, Michele Merli, Marco Lucioni

|Jun 12, 2025
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study.

Alberto Fresa, Idanna Innocenti, Annamaria Tomasso

|Apr 16, 2025
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort.

Andrea Serafin, Alessandro Cellini, Enrica Antonia Martino

|Mar 19, 2025
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi.

Rexhep Durmo, Stephane Chauvie, Federico Fallanca

Pageof 4

Frequent Collaborators

14 joint publications

Candida Vitale

10 joint publications

Luca Laurenti

9 joint publications

Livio Trentin

7 joint publications

Massimo Gentile